JPRN-UMIN000050228
Not yet recruiting
未知
Observational Study of the effect of SGLT2 inhibitor on Glycemic Control Indices - Observational Study of the effect of SGLT2 inhibitor on Glycemic Control Indices
agoya University0 sites4,250 target enrollmentApril 1, 2023
Conditionsdiabetes mellitus
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- diabetes mellitus
- Sponsor
- agoya University
- Enrollment
- 4250
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
The REFORM TrialType 2 diabetes and Heart FailureTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2014-002742-42-GBniversity of Dundee/ NHS Tayside56
Completed
Not Applicable
The inhibitory effects of the SGLT2 inhibitor for progression of diabetic nephropathy, in the patients with type 2 diabetes in Japan.diabetic nephropathy in type 2 diabetes mellitusJPRN-UMIN000016754Saitama Medical Center, Saitama Medical University50
Recruiting
Not Applicable
Influence of SGLT2 inhibitor on myocardial fatty acid metabolismtype 2 diabetesJPRN-jRCT1041190002Kumazaki Setsuo40
Completed
Not Applicable
Prospective observational study of tofogliflozin in patients with type 2 diabetesType 2 DiabetesJPRN-jRCT1090220212agoya Medical Association600
Completed
Not Applicable
Effects of treatment with SGLT2 inhibitor on the initiation of continuous positive airway pressure therapy in type 2 diabetic patients with obstructive sleep apnea syndromeType 2 diabetesJPRN-UMIN000045226Akishima Clinic16